Impact of Incentives and Information on Quality and Utilization in Primary Care 2014, Baseline Survey
Philippines, 2014
Get MicrodataCreated on
Dec 05, 2022
Last modified
Dec 05, 2022
Page views
45754
Downloads
758
Others [spontaneous] (C3_8_Spon)
Data file: E05_noID
Overview
Valid:
23
Invalid:
0
Type:
Discrete
Start:
2030
End:
2088
Width:
59
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ASA, HCT2 | 1 |
4.3%
|
|
| Alpha agonist; clonidine | 1 |
4.3%
|
|
| Aspirin | 9 |
39.1%
|
|
| B complex | 1 |
4.3%
|
|
| Clonidine | 1 |
4.3%
|
|
| Cloridin (Catapress) | 1 |
4.3%
|
|
| Cozartan, aspirin | 1 |
4.3%
|
|
| Diretic/Betablock; Diretic ACE | 1 |
4.3%
|
|
| Furosemide | 1 |
4.3%
|
|
| It depends the perfect condition, AGE, Methyldopia-pregnant | 1 |
4.3%
|
|
| Lifestyle Modification | 1 |
4.3%
|
|
| Methyldopa, Aldomet for pregnant mother | 1 |
4.3%
|
|
| Methyldopa-for pregnant mother | 1 |
4.3%
|
|
| Symvastatin | 1 |
4.3%
|
|
| Telmisartan | 1 |
4.3%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.